A quantity of cannabis recalls over labeling errors and mould is an indication that the federal well being division’s regulatory oversight is working, an business consultant stated.
Seven notices involving cannabis have been posted to Health Canada’s recall portal since Oct. 17, representing a fraction of the general manufacturing. No recall notices have been posted in the 9 months previous to the nationwide adult-use launch.
(The final recall earlier than legalization was when Leamington, Ontario-based Aphria issued the voluntary recall for 2 tons of dried marijuana on account of a labeling error in January 2018.)
“Some cases of mold and contamination of product have resulted in recalls of some products and batches,” stated Allan Rewak, government director of the Cannabis Canada Council.
“So the fact that we have seen recalls is a sign that the oversight is working, ensuring a consistent quality product and protecting the health can safety of Canadians,” he stated.
The group’s membership accounts for roughly 80% of Canada’s licensed cultivation in phrases of sq. footage.
The most up-to-date recall got here Feb. four when Aurora Cannabis recalled 2,180 models of cannabis product bought between Dec. 14, 2018 and Jan. 28, 2019, in Alberta and Quebec.
In that occasion, CBD capsules and a dried cannabis pressure have been bought with incorrect labels on the surface of their packing containers.
The recall famous that consumption of affected merchandise might cause sudden results resulting from a higher amount of THC.
“To date, Aurora received three complaints related to the recalled lots. Aurora has received one adverse reaction report regarding the ‘CBD caps’ product. Health Canada has not received any complaints related to the recalled lots,” based on the discover.
Health Canada recall information
Health Canada just lately revealed the primary information to advertise compliance with recall necessities and helps license holders perceive their position in a voluntary recall.
Read the complete “Cannabis Voluntary Recall Guide” right here.
The information is relevant to the next federal cannabis license and allow holders:
- Cultivator (nurseries, commonplace and micro)
- Processor (commonplace and micro)
- Analytical testing
- Import (medical, analysis and hemp)
- Export (medical, analysis and hemp)
Health Canada says the brand new information supplies info on necessities to:
- Establish and keep a system of management for the recall of cannabis or cannabis merchandise.
- Keep sale, distribution and export data for cannabis or cannabis merchandise.
- Report voluntary recalls of cannabis or cannabis merchandise to Health Canada.
- Conduct a voluntary recall of cannabis or cannabis merchandise.
Recalls since October 2018
CannTrust recalled roughly 714 models of Liiv THC cannabis oil bought in New Brunswick between Jan. four and Jan. 17. No complaints have been acquired by the well being regulator.
Earlier in January, Up Cannabis recalled about 1,428 models of Eldo dried cannabis bought in Alberta.
“The affected product may contain mold. In certain individuals, exposure to mold can result in allergic symptoms such as sneezing, coughing, wheezing, runny nose or nasal congestion, and watery eyes or itchy eyes,” in accordance with the recall discover.
The product was bought between Nov. 29, 2018, and Jan. four, 2019.
Also in January, a labeling error prompted CannTrust to difficulty a voluntary recall for a cannabis oil bought in 40 milliliter bottles.
Bonify recalled roughly 5,883 models of product on Dec. 24 because of labeling errors and record-keeping points with manufacturing paperwork that will not meet the necessities beneath the Cannabis Regulations.
Other recalls embrace:
Health Canada later suspended Bonify’s authority to promote marijuana after an investigation discovered the Winnipeg-based agency possessed, distributed and bought product bought from an unlawful supply.
Matt Lamers might be reached at [email protected]
To join our weekly worldwide cannabis enterprise publication, click on right here.